We serve Chemical Name:4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine CAS:394655-11-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
CAS.NO:394655-11-9
Synonyms:GL-0053;2-Phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
Molecular Formula:C15H16N2
Molecular Weight:224.30100
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:407.1ºC at 760mmHg
Density:1.61 g/cm3
Index of Refraction:1.575
PSA:24.06000
Exact Mass:224.13100
LogP:3.93140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like GL-0053 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine Use and application,2-Phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine technical grade,usp/ep/jp grade.
Related News: It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine manufacturer The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine supplier With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine vendor With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine factory It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering.